MiMedx Group, Inc.

NASDAQ:MDXG

9.1 (USD) • At close December 20, 2024
Bedrijfsnaam MiMedx Group, Inc.
Symbool MDXG
Munteenheid USD
Prijs 9.1
Beurswaarde 1,337,208,600
Dividendpercentage 0%
52-weken bereik 5.47 - 10.14
Industrie Biotechnology
Sector Healthcare
CEO Mr. Joseph H. Capper
Website https://www.mimedx.com

An error occurred while fetching data.

Over MiMedx Group, Inc.

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing

Vergelijkbare Aandelen

Inovio Pharmaceuticals, Inc. logo

Inovio Pharmaceuticals, Inc.

INO

1.84 USD

IDEAYA Biosciences, Inc. logo

IDEAYA Biosciences, Inc.

IDYA

25.61 USD

Centessa Pharmaceuticals plc logo

Centessa Pharmaceuticals plc

CNTA

17.16 USD

Accolade, Inc. logo

Accolade, Inc.

ACCD

3.48 USD

Agenus Inc. logo

Agenus Inc.

AGEN

2.83 USD

Leafly Holdings, Inc. logo

Leafly Holdings, Inc.

LFLY

1.62 USD

Tarsus Pharmaceuticals, Inc. logo

Tarsus Pharmaceuticals, Inc.

TARS

52.91 USD

AxoGen, Inc. logo

AxoGen, Inc.

AXGN

15.64 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)